Effect of Rifampin on Bosutinib When Both Are Given to Healthy People

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: Bosutinib

Study type: Interventional

Funder types: Industry

Identifiers

NCT00725426

3160A4-1106

Details and patient eligibility

About

Study to examine whether rifampin has an effect on the pharmacokinetics of bosutinib.

Enrollment: 24 estimated patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy men age 18-50
• Healthy women of nonchildbearing potential, age 18-50

Trial design

24 participants in 1 patient group

1

Experimental group

Description:

Bosutinib

Treatment:

Drug: Bosutinib